Effect of oral iron chelator L1 on iron absorption in man.
Dresow
B
B
UKE-Universität Hamburg, Germany.
Fischer
R
R
Nielsen
P
P
Gabbe
E E
EE
Piga
A
A
D000284:Administration, Oral; D001205:Ascorbic Acid / Q000493:pharmacokinetics*; D000077543:Deferiprone; D003692:Delayed-Action Preparations; D005296:Ferrous Compounds / Q000493:pharmacokinetics*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007501:Iron / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism*; D008297:Male; D011728:Pyridones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*
D003692:Delayed-Action Preparations; D005296:Ferrous Compounds; D007502:Iron Chelating Agents; D011728:Pyridones; C051140:iron(II)-ascorbic acid complex; D000077543:Deferiprone; D007501:Iron; D001205:Ascorbic Acid